This HTML5 document contains 49 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
n7http://en.wikipedia.org/w/index.php?title=GSK_299423&oldid=
dcthttp://purl.org/dc/terms/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
dbpedia-wikidatahttp://wikidata.dbpedia.org/resource/
dbthttp://dbpedia.org/resource/Template:
n12http://commons.wikimedia.org/wiki/Special:FilePath/GSK_299423.png?width=
n20http://commons.wikimedia.org/wiki/Special:FilePath/GSK_299423.
rdfshttp://www.w3.org/2000/01/rdf-schema#
n18http://en.wikipedia.org/w/index.php?title=GSK_299423&action=
n15http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
n14http://rdf.freebase.com/ns/m.
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n19http://wikidata.org/entity/
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbchttp://dbpedia.org/resource/Category:
dbphttp://dbpedia.org/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://dbpedia.org/resource/Category:Heterocyclic_compounds_(2_rings)
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/
Subject Item
wikipedia-en:GSK_299423
foaf:primaryTopic
dbr:GSK_299423
Subject Item
dbr:GSK-299423
dbo:wikiPageRedirects
dbr:GSK_299423
Subject Item
dbr:GSK_299423
rdf:type
n15:ChemicalObject owl:Thing dbo:ChemicalCompound dbo:ChemicalSubstance wikidata:Q11173
dbo:thumbnail
n12:300
owl:sameAs
dbpedia-wikidata:Q5514569 n14:0crhpf5 n19:Q5514569
foaf:isPrimaryTopicOf
wikipedia-en:GSK_299423
rdfs:comment
GSK 299423 or GlaxoSmithKline 299423 is an antibiotic chemical compound that has been identified as potentially effective in treating patients infected with bacteria expressing the New Delhi metallo-beta-lactamase. The antibiotic inhibits the enzyme topoisomerase, which bacteria need to replicate. No animal studies have been reported. No application has been made for human clinical trials.
rdfs:label
GSK 299423
dbo:abstract
GSK 299423 or GlaxoSmithKline 299423 is an antibiotic chemical compound that has been identified as potentially effective in treating patients infected with bacteria expressing the New Delhi metallo-beta-lactamase. The antibiotic inhibits the enzyme topoisomerase, which bacteria need to replicate. No animal studies have been reported. No application has been made for human clinical trials.
dbo:iupacName
4-(2-(4-(([1,3]oxathiolo[5,4-c]pyridin-6-ylmethyl)amino)piperidin-1-yl)ethyl)-6-methoxyquinoline-3-carbonitrile
dbo:wikiPageEditLink
n18:edit
dbo:wikiPageExtracted
2019-07-12T03:34:25Z
dbo:wikiPageHistoryLink
n18:history
dbo:wikiPageID
28367329
dbo:wikiPageLength
2829
dbo:wikiPageModified
2019-07-12T03:34:20Z
dbo:wikiPageOutDegree
13
dbo:wikiPageRevisionID
905885980
dbo:wikiPageRevisionLink
n7:905885980
dbp:wikiPageUsesTemplate
dbt:Chembox_Identifiers dbt:PDB dbt:Chembox_Properties dbt:Chemspidercite dbt:Reflist dbt:Chembox dbt:Chembox_Hazards dbt:Fdacite dbt:Cascite dbt:Bacteria dbt:Antibiotic-stub dbt:Stdinchicite
dct:subject
dbc:Nitrogen_heterocycles n13: dbc:Sulfur_heterocycles dbc:Phenol_ethers dbc:Quinolines dbc:Oxygen_heterocycles dbc:Piperidines dbc:Antibiotics dbc:Nitriles
foaf:depiction
n20:png
Subject Item
dbr:C25H27N5O2S
dbo:wikiPageRedirects
dbr:GSK_299423
Subject Item
dbr:GSK299423
dbo:wikiPageRedirects
dbr:GSK_299423